Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-009852
Filing Date
2023-05-15
Accepted
2023-05-15 16:16:03
Documents
108
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q lci-20230331x10q.htm   iXBRL 10-Q 2124947
2 EX-3.9 lci-20230331xex3d9.htm EX-3.9 196157
3 EX-31.1 lci-20230331xex31d1.htm EX-31.1 10353
4 EX-31.2 lci-20230331xex31d2.htm EX-31.2 10419
5 EX-32 lci-20230331xex32.htm EX-32 7978
6 GRAPHIC lci-20230331xex3d9001.jpg GRAPHIC 13062
7 GRAPHIC lci-20230331xex3d9002.jpg GRAPHIC 30712
8 GRAPHIC lci-20230331xex3d9003.jpg GRAPHIC 8128
9 GRAPHIC lci-20230331xex3d9005.jpg GRAPHIC 25381
10 GRAPHIC lci-20230331xex3d9006.jpg GRAPHIC 13863
11 GRAPHIC lci-20230331xex3d9007.jpg GRAPHIC 63564
12 GRAPHIC lci-20230331xex3d9008.jpg GRAPHIC 19203
13 GRAPHIC lci-20230331xex3d9009.jpg GRAPHIC 22305
14 GRAPHIC lci-20230331xex3d9010.jpg GRAPHIC 24702
15 GRAPHIC lci-20230331xex3d9011.jpg GRAPHIC 19805
16 GRAPHIC lci-20230331xex3d9012.jpg GRAPHIC 10777
17 GRAPHIC lci-20230331xex3d9014.jpg GRAPHIC 23814
  Complete submission text file 0001558370-23-009852.txt   10247037

Data Files

Seq Description Document Type Size
18 EX-101.SCH lci-20230331.xsd EX-101.SCH 59235
19 EX-101.CAL lci-20230331_cal.xml EX-101.CAL 69197
20 EX-101.DEF lci-20230331_def.xml EX-101.DEF 240132
21 EX-101.LAB lci-20230331_lab.xml EX-101.LAB 578094
22 EX-101.PRE lci-20230331_pre.xml EX-101.PRE 442381
102 EXTRACTED XBRL INSTANCE DOCUMENT lci-20230331x10q_htm.xml XML 1877129
Mailing Address 9000 STATE ROAD 9000 STATE ROAD PHLADELPHIA PA 19136
Business Address 9000 STATE RD PHILADELPHIA PA 19136 2153339000
LANNETT CO INC (Filer) CIK: 0000057725 (see all company filings)

EIN.: 230787699 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-31298 | Film No.: 23922584
SIC: 2834 Pharmaceutical Preparations